Atlas Trials

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity

Clinical trial NCT06690905 · COMPLETED

Trial details

NCT number
NCT06690905
Sponsor
CR-CSSS Champlain-Charles-Le Moyne
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
InfectionsObesity and Obesity-related Medical Conditions
Start date
2025-02-26
Primary completion
2025-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.